Browsing Tag
ASCRS
5 posts
Glaukos at ASCRS 2026: Epioxa commercial launch and the growing case for interventional eye care
Glaukos presents Epioxa and iDose TR data at ASCRS 2026. Full coverage of the keratoconus launch, glaucoma pipeline, Q4 results, and 2026 revenue guidance for NYSE: GKOS.
Viatris and the presbyopia drug race: What ASCRS 2026 data means for the MR-141 FDA decision in October
Viatris presents full VEGA-3 Phase 3 data for MR-141 presbyopia drop at ASCRS 2026. FDA PDUFA date is October 17, 2026. Market context, competitive landscape, and investor outlook.
AI in ophthalmology at ASCRS 2026: What the Washington DC meeting is signalling about the specialty’s technology future
Kerry Solomon's Binkhorst Lecture at ASCRS 2026 in Washington DC puts AI at the centre of ophthalmology. Coverage of Zeiss VisioGen, IOL calculators, and Sean Ianchulev's Kelman Lecture.
ASCRS 2026 in Washington DC: What ophthalmologists need to know
ASCRS 2026 annual meeting runs April 10-13 in Washington DC. Full guide to the programme, key speakers, technology announcements, SightLine, and CME for anterior segment surgeons.
Johnson & Johnson shows new TECNIS PureSee data at ASCRS 2026 as JNJ eyes deeper ophthalmology upside
Johnson & Johnson unveiled new TECNIS PureSee data at ASCRS 2026. Read how it could reshape cataract surgery growth and JNJ’s medtech outlook.